Case Report Open Access
Copyright ©2007 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 28, 2007; 13(40): 5403-5407
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5403
Reactive lymphoid hyperplasia of the liver: A case report and review of literature
Takuro Machida, Michiaki Hirayama, Shoichi Horita, Department of Internal Medicine, Hokkaido Gastroenterology Hospital, Sapporo, Hokkaido 065-0041, Japan
Toshiyuki Takahashi, Department of Pathology, Hokkaido Gastroenterology Hospital, Sapporo, Hokkaido 065-0041, Japan
Tomoo Itoh, Department of Pathology, Hokkaido University Hospital, Sapporo, Hokkaido, 060-8648, Japan
Takayuki Morita, Department of Surgery, Hokkaido Gastroenterology Hospital, Sapporo, Hokkaido 065-0041, Japan
Author contributions: All authors contributed equally to the work.
Correspondence to: Toshiyuki Takahashi, MD, PhD, Department of Pathology, Hokkaido Gastroenterology Hospital, Honcho 1-1-2-10, Higashi-ku, Sapporo, Hokkaido 065-0041, Japan. ricoh@hgh.or.jp
Telephone: +81-11-7841811-540 Fax: +81-11-7841838
Received: June 28, 2007
Revised: August 6, 2007
Accepted: September 4, 2007
Published online: October 28, 2007

Abstract

A case of a 53-year-old female patient with reactive lymphoid hyperplasia (RLH), clinically designated as pseudolymphoma of the liver is described in this article. The patient was admitted to our hospital for further evaluation of hepatic tumors incidentally discovered at another hospital. Various diagnostic methods, including ultrasonography (US), computerized tomography (CT), magnetic resonance imaging (MRI) and hepatic angiography displayed three small lesions in the liver with outstanding findings consistent with hepatocellular carcinoma (HCC). Surgical resection was performed and the three lesions were microscopically diagnosed as RLH of the liver. The lesions comprised a massive infiltration of lymphoid cells with follicles and hyalinized inter-follicular spaces. Immunohistochemical examination revealed that infiltrating lymphocytes had no prominent nuclear atypia and polyclonality. RLH of the liver is a very rare condition and only twelve cases have been reported in the English literature. Majority of the reported cases were middle-aged women and about half of them had some immunologic abnormalities such as autoimmune thyroiditis, Sjogren's syndrome, primary immunodeficiency, primary biliary cirrhosis. Since they are often clinically misdiagnosed as HCC, surgery is the choice of treatment for these patients. Although their pathology resembles malignant lymphoma, the clinical course is completely benign. The authors propose that RLH of the liver can be discriminated from HCC by its clinical features.

Key Words: Reactive lymphoid hyperplasia, Pseudo-lymphoma, Hepatocellular carcinoma, Autoimmune thyroiditis, Immunohistochemistry



INTRODUCTION

Reactive lymphoid hyperplasia (RLH) is a benign nodular lesion, histopathologically characterized by marked proliferation of non-neoplastic, polyclonal lymphocytes forming follicles with an active germinal center. The lesion is encountered in various organs such as the orbit[1], lung[2], skin[3,4] and gastrointestinal tract[5-7]. However, disease of the liver is quite rare, with only 12 cases reported in the English literature. We have recently encountered a patient with 3 RLH lesions occurred in the liver. In this paper, the clinicopathological and radiographic characteristics of this unique disorder are discussed. Problems in differential diagnosis from malignant diseases, including malignant lymphoma and hepatocellular carcinoma, are also discussed.

CASE REPORT

A 53-year-old Japanese woman with a history of autoimmune thyroiditis was admitted to our hospital for further evaluation of hepatic lesions incidentally discovered on abdominal ultrasonography. The patient was asymptomatic on admission and her condition was generally good. Physical examination revealed no abnormalities. Relevant laboratory tests disclosed slightly elevated lactate dehydrogenase activity (547 IU/L; normal range: 120-245 IU/L), thymol turbidity (7.2 U/L; normal range: 0.0-4.0 U/L) and zinc sulfate turbidity (13.0 U/L; normal range: 4.0-12.0 U/L), although other hepatic function tests including serum asparate aminotransferase, serum alanine aminotransaminase and total bilirubin were within normal range. Levels of serum thyroid-stimulating hormone (10.22μIU/mL; normal range: 0.35-3.73μU/mL) and antinuclear antibody (80 ×; normal range: < 40 ×) were elevated due to autoimmune thyroiditis. Both hepatitis B surface antigen and anti-hepatitis C virus antibody were negative. Tumor markers including alpha-fetoprotein and protein induced by vitamin K antagonist-II were negative.

Precise US examination disclosed 2 hypoechoic nodules in the posterior segment and 1 nodule in the medial segment of the liver (13, 11 and 8 mm in diameter) respectively. Dynamic CT performed in the planes of lesions demonstrated a slight hyperdensity in the arterial phase followed by hypodense areas with pronounced enhancement along the tumor rims in the portal phase. The lesion in segment 7 was conspicuously enhanced through the early phase on CT angiography (Figure 1A). The tumor rim was continuatively intensified through the delayed phase, and radial enhancement toward surrounding liver parenchyma was also recognized (Figure 1B). The lesion was identified as a portal flow defect on CT with arterial portography. On MRI, tumor gave a hypointense signal on T1-weighted imaging (Figure 2A) and a hyperintense signal on T2-weighted imaging (Figure 2B). The tumor rim was underscored as an annular enhancement in the delayed phase, similar to dynamic CT (Figure 2C). Other lesions within segments 4 and 6 showed equivalent hemodynamics to the tumor in segment 7. Hepatic angiography of the 3 lesions also demonstrated distinct tumor staining in the arterial phase, following dense staining along tumor rims in the parenchymal-venous phase. As all images suggested hepatocellular carcinoma, posterior segmentectomy and partial resection of the medial segment of the liver were performed.

Figure 1
Figure 1 CT angiography showing the conspicuously enhanced lesion in segment 7 through the early phase (arrows) (A) and intensified tumor rim enhancement through the delayed phase along with radial enhancement (arrowheads) (B).
Figure 2
Figure 2 MRI displaying a hypointense signal on T1-weighted imaging (arrow) (A), a hyperintense signal on T2-weighted imaging of the lesion (arrow) (B), and enhanced tumor rim in the delayed phase of MRI (arrow) (C).

The resected liver displayed smooth surfaces and normal appearance. On the cut section, lesions were well-circumscribed, but not encapsulated white-yellowish nodules with irregular shapes (Figure 3). The 3 nodules exhibited similar microscopic findings, comprising a massive infiltration of lymphoid cells with follicles and hyalinized interfollicular spaces at low magnification (Figure 4A). Lymph follicles varied in size and shape with germinal centers composed of small or large lymphoid cells and tingible body macrophages. Interfollicular areas mostly comprised mature lymphocytes with no prominent nuclear atypia and a small amount of infiltrated plasma cells and histiocytes (Figure 4B). Strands of amorphous, somewhat-dense hyalinized material accompanied with capillaries were observed in interfollicular areas (Figure 4C). In some parts, fibrous materials aggregated as nodular structures of various sizes. Bile ductule proliferation was seen along the lesion edges. Portal areas apart from nodules showed irregular expansion with infiltration of small mature lymphocytes (Figure 4D). Immunohistochemical studies on paraffin-embedded tissue sections for CD3, CD5, CD10, CD20, bcl-2 and both and immunoglobulin light chains were undertaken using the avidin-biotin-peroxidase complex technique. Follicles mainly comprised CD20-positive lymphocytes, while CD3-positive cells were distributed interfollicularly and circumferentially around follicles (Figure 5). Distributions were similar to that seen in reactive hyperplasia of lymph nodes. Lymphoid cells in follicles showed ordinary immunoreactivity, while cells in the mantle zone were positive for CD5 and cells in the germinal center were positive for CD10. Bcl-2 reacted only to lymphocytes in marginal or circumferential areas of follicles, but not in central regions. Scattered plasma cells were positive for both κ and λ light chains at an equal frequency. These immunohistochemical results indicate that lymph follicles were of reactive origin, but not of neoplastic, and that the lesion was composed of polyclonal lymphocytes and plasma cells. A genetic investigation of clonality in the immunoglobulin heavy chains (IgH) using a previously reported polymerase chain reaction method[8] with DNA from paraffin-embedded tissue was also performed. No clonal IgH gene rearrangement was detected with satisfactory negative and positive controls. The 3 lesions were thus pathologically diagnosed as RLH of the liver.

Figure 3
Figure 3 Macroscopy of tumor in segment 7 demonstrating the lesion as a well-circumscribed, white-yellowish nodule on the cut surface.
Figure 4
Figure 4 Microscopy revealing lesions comprising massive lymphoid cell infiltration with prominent follicles and hyalinized interfollicular spaces at low magnification (HE, X 2. 5) (A), interfollicular areas mainly comprising mature lymphocytes with no nuclear atypia (HE, X 50) (B), strands of amorphous hyalinized material accompanying capillaries in interfollicular areas (HE, X 50) (C), and portal areas apart from the nodules with irregular expansion of infiltration of small mature lymphocytes (HE, X 25) (D).
Figure 5
Figure 5 Immunohistochemistry discovering follicles mainly comprising CD20-positive lymphocytes (X 50) (A), and interfollicularly and circumferentially distributed CD3-positive cells compared to follicles (X 50) (B).

Postoperative course was relatively good and the patient experienced no signs of recurrence for 22 mo.

DISCUSSION

Although RLH can be found in various organs, including the gastrointestinal tract[5-7], orbit[1], lung[2] and skin[3,4], its occurrence in the liver is rare. To the best of our knowledge, only 14 lesions in 12 other cases of hepatic RLH of the liver have been reported in the English literature since the first case report by Snover et al[9] in 1981, with this case representing the thirteenth (Table 1). RLH occurs predominantly in middle-aged women, with a mean age of 54.1 years (range 15-72 years, Table 1). Although the pathogenesis remains unknown, an association between development of hepatic RLH and systemic or local immunological abnormalities has been suggested in earlier reports[10,11]. In fact, 6 of 13 patients, including the present, have displayed some immunological complications, such as autoimmune thyroiditis[10], Sjogren's syndrome[11], primary immunodeficiency (PI)[9], and primary biliary cirrhosis (PBC)[12](Table 1). Two cases have been reported in association with hepatitis B (HB) virus or hepatitis C (HC) virus infection[13,14] (Table 1). The patient with hepatitis B was treated with interferon (IFN)-α[13]. Whether hepatitis viral infection is involved in hepatic RLH remains unclear. However, the findings in these patients indicate that continuous stimulation from cytokines such as IFN-αor hepatitis viruses may cause RLH of the liver.

Table 1 Reported cases of RLH of the liver.
CaseReference #Age (yr)SexComplicationsNeedle biopsyPreoperative diagnosisTumor numberTumor size (mm)Treatment
1915FPIDoneCirrhosis
21342FHBNoneHCC315, 14, and smallerResection
31047FAutoimmune thyroiditisNoneHCC117Resection
41149FSjogren's syndromeDoneSuspicious HCC120Resection
51252FPBCNonePBC14Transplantation
61256FPBCNonePBC115Transplantation
71256MDiverticulitisNoneNot reported17Resection
81959FDiabetesNoneMalignant tumor19Resection
91666FDiabetesDoneSuspicious lymphoma115Resection
101767FNoneNoneHCC120Resection
111869FRenal cell carcinomaDoneMetastatic tumor117Resection
121472MGastric carcinoma HCNoneHCC117Resection
13Our case53FAutoimmune thyroiditisNoneHCC315, 12, and 10Resection

Saltzstein et al[15] has defined RLH as propagation of lymph-follicles constructed with lymphoid cells without cytological atypia, accompanied with a conspicuous, reactive germinal center. Katayanagi et al[16] and Tanizawa et al[17] have also proposed RLH as a localized lesion well-demarcated from the surrounding tissues and characterized by the presence of hyperplastic lymphoid follicles with polymorphic and polyclonal cell populations composed of small mature lymphocytes, mature plasma cells, macrophages and stromal fibrosis. The nodular lesion described herein seems to satisfy these histological criteria.

When RLH is diagnosed, malignant lymphoma must be excluded from the differential diagnosis. In the present case, immunohistochemical examination was performed to rule out malignant lymphoma. Germinal centers were considered non-neoplastic, based on negative results for bcl-2. In addition, lymphoid cells, including plasma cells, proliferating in the interfollicular area displayed polyclonal immunophenotypes. The results of a genetic investigation pertaining to IgH clonality also supported the histological findings. A diagnosis of RLH of the liver thus seems justified.

The lesion has been often misdiagnosed as a malignant tumor, since features are shared with hepatocellular carcinoma on various imaging modalities, namely detection as a hypoechoic mass on US, low density on CT with or without enhancement, low intensity on T1-weighted imaging and high intensity on T2-weighted imaging with magnetic resonance imaging, and tumor staining on hepatic angiography. Distinguishing RLH from hepatocellular carcinoma (HCC) is thus extremely difficult. Hepatectomy has therefore been performed for many patients[10-14,16-19] (Table 1). In the present case, the tumor rim displayed a sustained intensity accompanied with radial enhancement in addition to intratumoral hyperintensity on various imaging modalities. This prominent finding may represent increased capillaries within the nodule and massive infiltration of lymphocytes into portal areas around the lesion. Needle biopsy was indicated for only 4 patients in past reports[9,11,16,18] (Table 1), but it is not helpful for a confident diagnosis of this disease.

In conclusion, accumulation of reported cases with this benign lesion, including our patient, reveals some knowledge concerning the characteristics of this rare condition, such as female predominance, small tumor size, coexistent immunological disorder, and imaging features resembling HCC. The authors would like to emphasize that RLH should be included in the differential diagnosis of small hepatic lesions, particularly in middle-aged women with suspected HCC.

Footnotes

S- Editor Liu Y L- Editor Wang XL E- Editor Li JL

References
1.  1 Knowles DM, Jakobiec FA, McNally L, Burke JS. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990;21:959-973.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Abbondanzo SL, Rush W, Bijwaard KE, Koss MN. Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. Am J Surg Pathol. 2000;24:587-597.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Caro WA, Helwig HB. Cutaneous lymphoid hyperplasia. Cancer. 1969;24:487-502.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM. Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features. Am J Surg Pathol. 1999;23:88-96.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Tokunaga O, Watanabe T, Morimatsu M. Pseudolymphoma of the stomach. A clinicopathologic study of 15 cases. Cancer. 1987;59:1320-1327.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Abbondanzo SL, Sobin LH. Gastric "pseudolymphoma": a retrospective morphologic and immunophenotypic study of 97 cases. Cancer. 1997;79:1656-1663.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Kojima M, Itoh H, Motegi A, Sakata N, Masawa N. Localized lymphoid hyperplasia of the rectum resembling polypoid mucosa-associated lymphoid tissue lymphoma: a report of three cases. Pathol Res Pract. 2005;201:757-761.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Orba Y, Tanaka S, Nishihara H, Kawamura N, Itoh T, Shimizu M, Sawa H, Nagashima K. Application of laser capture microdissection to cytologic specimens for the detection of immunoglobulin heavy chain gene rearrangement in patients with malignant lymphoma. Cancer. 2003;99:198-204.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Snover DC, Filipovich AH, Dehner LP, Krivit W. 'Pseudolymphoma'. A case associated with primary immunodeficiency disease and polyglandular failure syndrome. Arch Pathol Lab Med. 1981;105:46-49.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Nagano K, Fukuda Y, Nakano I, Katano Y, Toyoda H, Nonami T, Nagasaka T, Hayakawa T. Reactive lymphoid hyperplasia of liver coexisting with chronic thyroiditis: radiographical characteristics of the disorder. J Gastroenterol Hepatol. 1999;14:163-167.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Okubo H, Maekawa H, Ogawa K, Wada R, Sekigawa I, Iida N, Maekawa T, Hashimoto H, Sato N. Pseudolymphoma of the liver associated with Sjögren's syndrome. Scand J Rheumatol. 2001;30:117-119.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Sharifi S, Murphy M, Loda M, Pinkus GS, Khettry U. Nodular lymphoid lesion of the liver: an immune-mediated disorder mimicking low-grade malignant lymphoma. Am J Surg Pathol. 1999;23:302-308.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Ohtsu T, Sasaki Y, Tanizaki H, Kawano N, Ryu M, Satake M, Hasebe T, Mukai K, Fujikura M, Tamai M. Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B. Intern Med. 1994;33:18-22.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Kim SR, Hayashi Y, Kang KB, Soe CG, Kim JH, Yang MK, Itoh H. A case of pseudolymphoma of the liver with chronic hepatitis C. J Hepatol. 1997;26:209-214.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Saltzstein SL. Pulmonary malignant lymphomas and pseu-dolymphomas: Classification, therapy, and prognosis. Cancer. 1963;16:928-955.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Katayanagi K, Terada T, Nakanuma Y, Ueno T. A case of pseudolymphoma of the liver. Pathol Int. 1994;44:704-711.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Tanizawa T, Eishi Y, Kamiyama R, Nakahara M, Abo Y, Sumita T, Kawano N. Reactive lymphoid hyperplasia of the liver characterized by an angiofollicular pattern mimicking Castleman's disease. Pathol Int. 1996;46:782-786.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Pantanowitz L, Saldinger PF, Kadin ME. Pathologic quiz case: Hepatic mass in a patient with renal cell carcinoma. Arch Pathol Lab Med. 2001;125:577-578.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Isobe H, Sakamoto S, Sakai H, Masumoto A, Sonoda T, Adachi E, Nawata H. Reactive lymphoid hyperplasia of the liver. J Clin Gastroenterol. 1993;16:240-244.  [PubMed]  [DOI]  [Cited in This Article: ]